Ophthalytics’ AI Retina Screening System Makes a Splash at ARVO 2023
Ophthalytics stole the spotlight at ARVO 2022, the world’s largest ophthalmology conference, with groundbreaking AI models.
| We’re on a Mission
to Advance Healthcare
Our mission is rooted in harnessing deep-learning AI to advance health equity by providing life-changing care to underserved communities. Although we are starting with diabetic retinopathy – and Nsight360 – we are already working on AI applications that will provide early diagnosis for a host of other diseases.
![half-circle-tablet-purple](https://360intelligentdiagnostics.com/wp-content/uploads/2024/08/half-circle-tablet-purple.png)
![half-circle-purple](https://360intelligentdiagnostics.com/wp-content/uploads/2024/08/half-circle-purple.png)
| We’re on a Mission
to Advance Healthcare
Our mission is rooted in harnessing deep-learning AI to advance health equity by providing life-changing care to underserved communities. Although we are starting with diabetic retinopathy – and Nsight360 – we are already working on AI applications that will provide early diagnosis for a host of other diseases.
![half-circle-tablet-purple](https://360intelligentdiagnostics.com/wp-content/uploads/2024/08/half-circle-tablet-purple.png)
![half-circle-purple](https://360intelligentdiagnostics.com/wp-content/uploads/2024/08/half-circle-purple.png)